Zimmer Biomet Holdings, Inc. (ZBH) Upgraded at Edward Jones

Edward Jones upgraded shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, Marketbeat Ratings reports.

Several other research analysts have also recently commented on ZBH. Piper Jaffray Companies lowered shares of Zimmer Biomet Holdings from an overweight rating to a neutral rating in a research report on Thursday, November 2nd. Oppenheimer Holdings, Inc. set a $137.00 price target on shares of Zimmer Biomet Holdings and gave the stock a buy rating in a research report on Monday, August 14th. Jefferies Group LLC reiterated a buy rating and set a $136.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, November 3rd. Stifel Nicolaus reiterated a hold rating and set a $120.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, November 3rd. Finally, Royal Bank Of Canada reduced their price target on shares of Zimmer Biomet Holdings to $125.00 and set an outperform rating on the stock in a research report on Tuesday, November 7th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus price target of $134.00.

Shares of Zimmer Biomet Holdings (ZBH) traded down $1.09 on Thursday, hitting $110.75. 973,400 shares of the stock traded hands, compared to its average volume of 1,738,246. Zimmer Biomet Holdings has a 12 month low of $95.63 and a 12 month high of $133.49. The company has a market capitalization of $22,423.88, a PE ratio of 13.72, a PEG ratio of 1.72 and a beta of 1.17. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.29% and a net margin of 8.36%. The business had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same period in the prior year, the business posted $1.79 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. sell-side analysts forecast that Zimmer Biomet Holdings will post 8.03 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Zimmer Biomet Holdings, Inc. (ZBH) Upgraded at Edward Jones” was originally reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.chaffeybreeze.com/2017/11/12/zimmer-biomet-holdings-inc-zbh-upgraded-at-edward-jones.html.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Enterprise Financial Services Corp grew its holdings in shares of Zimmer Biomet Holdings by 0.3% during the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after buying an additional 9 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Zimmer Biomet Holdings by 3.9% during the second quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after buying an additional 33 shares during the last quarter. CWA Asset Management Group LLC grew its holdings in shares of Zimmer Biomet Holdings by 1.8% during the second quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock valued at $251,000 after buying an additional 34 shares during the last quarter. Advisory Services Network LLC grew its holdings in shares of Zimmer Biomet Holdings by 1.0% during the second quarter. Advisory Services Network LLC now owns 3,690 shares of the medical equipment provider’s stock valued at $474,000 after buying an additional 37 shares during the last quarter. Finally, Palladium Partners LLC grew its holdings in shares of Zimmer Biomet Holdings by 1.7% during the second quarter. Palladium Partners LLC now owns 2,501 shares of the medical equipment provider’s stock valued at $321,000 after buying an additional 41 shares during the last quarter. Hedge funds and other institutional investors own 85.80% of the company’s stock.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Analyst Recommendations for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply